By Spondylitis Association of America
A phase 2B clinical trial is now recruiting ankylosing spondylitis patients over the age of 18, who have been diagnosed before the age of 45, and have been experiencing symptoms for at least three months.
A recent study found a strong association between increased levels of an inflammatory marker in the gut and the subsequent development of Crohn’s disease in…
Biologic medications, such as TNF inhibitors (TNFi) and IL-17 inhibitors (IL-17i), are the current standard in rheumatologic treatment of moderate to severe spondyloarthritis. But what happens when patients don’t respond to this class of medications?
The following is an announcement from SAA about a third party clinical trial. SAA is not affiliated with this study, the researchers, or the drug manufacturer.
AbbVie is giving away 45 college scholarships of $15,000 each to U.S. residents living with inflammatory diseases.
Visit our careers page for available positions
16360 Roscoe Blvd. Ste. 100Van Nuys, CA 91406
(800) 777-8189 U.S. only
or (818) 892-1616*Please note: This is not a Crisis Hotline. If you are in a life-threatening crisis, please dial 911 for immediate help in the US. Please follow this link for crisis intervention resources.